首页> 外文期刊>Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine >Determination of biological vector characteristics and nanoparticle dimensions for radioimmunotherapy with radioactive nanoparticles.
【24h】

Determination of biological vector characteristics and nanoparticle dimensions for radioimmunotherapy with radioactive nanoparticles.

机译:用放射性纳米粒子进行放射免疫治疗的生物学载体特性和纳米粒子尺寸的确定。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Radioimmunotherapy with biological vector labeled with radioactive nanoparticles is investigated from a dosimetric point of view. Beta ((32)P, (90)Y) and low-energy X-ray radionuclides ((103)Pd) are considered. Dose distributions inside solid tumors have been calculated using MCNPX 2.5.0. Nanoparticle dimensions and biological vector characteristics are also determined in order to reach the 50Gy prescribed dose inside the entire tumor volume. The worst case of an avascular tumor is considered. Results show that for beta-emitting nanoparticles, a set of data (covering fraction, biological half-life, and nanoparticle radius) can be found within acceptable ranges (those of classical radioimmunotherapy). These sources (with E(max) approximately few MeV) can be used for the treatment of tumors with a maximum diameter of about 1cm. Low-energy X-rays (E<25keV) can be used to extend the range of tumor diameter to 4-5cm but require very tight biological vector characteristics.
机译:从剂量学角度研究了用放射性纳米颗粒标记的生物载体进行的放射免疫疗法。考虑使用β((32)P,(90)Y)和低能X射线放射性核素((103)Pd)。使用MCNPX 2.5.0计算了实体瘤内部的剂量分布。还确定了纳米粒子的尺寸和生物学载体特性,以便在整个肿瘤体积内达到50Gy的规定剂量。考虑到无血管肿瘤的最坏情况。结果表明,对于发射β的纳米粒子,可以在可接受的范围内(经典的放射免疫疗法)找到一组数据(覆盖率,生物学半衰期和纳米粒子半径)。这些来源(E(max)大约为几个MeV)可用于治疗最大直径约为1cm的肿瘤。低能X射线(E <25keV)可用于将肿瘤直径范围扩大到4-5cm,但需要非常严格的生物学载体特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号